Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update
- PMID: 1872310
- DOI: 10.1016/0002-9343(91)90412-q
Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update
Abstract
Non-insulin-dependent diabetes mellitus (NIDDM) is characterized by fasting hyperglycemia associated with defects in the pancreatic islet, the liver, and the peripheral tissues, which together comprise a feedback loop responsible for maintenance of glucose homeostasis. This review focuses on the key role of the endocrine pancreas alpha and beta cells to coordinate glucose output from the liver with glucose utilization. The basal rate of hepatic glucose utilization. The basal rate of hepatic glucose production is elevated in subjects with NIDDM, and this is positively correlated with the degree of fasting hyperglycemia. This increased rate of glucose release by the liver results from impaired hepatic sensitivity to insulin, reduced insulin secretion, and increased glucagon secretion. Though basal immunoreactive insulin levels in patients with NIDDM may appear normal when compared with healthy individuals, islet function testing at matched glucose levels reveals impairments of basal, steady-state, and stimulated insulin secretion due to a reduction in beta-cell secretory capacity and a reduced ability of glucose to suppress glucagon. The degree of impaired beta-cell responsiveness to glucose is closely related to the degree of fasting hyperglycemia but in a curvilinear fashion. The efficiency of glucose uptake by the peripheral tissues is also impaired due to a combination of decreased insulin secretion and defective cellular insulin action. This impairment becomes more important to the hyperglycemia as the islet alpha- and beta-cell function declines. Therapeutic interventions, to be effective, must reduce hepatic glucose production either by improving islet dysfunction and raising plasma insulin levels, or improving the effectiveness of insulin on the liver. Both result in a decline in the fasting glucose levels regardless of the cause of hyperglycemia. We conclude that NIDDM is characterized by a steady-state re-regulation of plasma glucose concentration at an elevated level in which islet dysfunction plays a necessary role. Treatment should be based on this physiologic understanding.
Similar articles
-
Islet dysfunction in non-insulin-dependent diabetes mellitus.Am J Med. 1988 Nov 28;85(5A):4-8. doi: 10.1016/0002-9343(88)90392-0. Am J Med. 1988. PMID: 3057894 Review.
-
The key role of islet dysfunction in type II diabetes mellitus.Clin Invest Med. 1995 Aug;18(4):247-54. Clin Invest Med. 1995. PMID: 8549009 Review.
-
Glucose regulation in non-insulin-dependent diabetes mellitus. Interaction between pancreatic islets and the liver.Am J Med. 1985 Aug 23;79(2B):6-12. doi: 10.1016/0002-9343(85)90579-0. Am J Med. 1985. PMID: 2863979 Review.
-
Acute and chronic effects of sulfonylurea drugs on pancreatic islet function in man.Diabetes Care. 1984 May-Jun;7 Suppl 1:25-34. Diabetes Care. 1984. PMID: 6376026 Review.
-
Banting lecture 1990. Beta-cells in type II diabetes mellitus.Diabetes. 1991 Feb;40(2):166-80. doi: 10.2337/diab.40.2.166. Diabetes. 1991. PMID: 1991568 Review.
Cited by
-
Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy.Ageing Res Rev. 2010 Oct;9(4):369-83. doi: 10.1016/j.arr.2010.04.004. Epub 2010 May 14. Ageing Res Rev. 2010. PMID: 20438881 Free PMC article. Review.
-
Exploration of N-Arylsulfonyl-indole-2-carboxamide Derivatives as Novel Fructose-1,6-bisphosphatase Inhibitors by Molecular Simulation.Int J Mol Sci. 2022 Sep 6;23(18):10259. doi: 10.3390/ijms231810259. Int J Mol Sci. 2022. PMID: 36142164 Free PMC article.
-
Quantitative path to deep phenotyping: Possible importance of reduced hepatic insulin degradation to type 2 diabetes mellitus pathogenesis.J Diabetes. 2018 Oct;10(10):778-783. doi: 10.1111/1753-0407.12794. Epub 2018 Jul 2. J Diabetes. 2018. PMID: 29961982 Free PMC article.
-
Hypothesis: Role of Reduced Hepatic Insulin Clearance in the Pathogenesis of Type 2 Diabetes.Diabetes. 2019 Sep;68(9):1709-1716. doi: 10.2337/db19-0098. Diabetes. 2019. PMID: 31431441 Free PMC article.
-
Actin dynamics regulated by the balance of neuronal Wiskott-Aldrich syndrome protein (N-WASP) and cofilin activities determines the biphasic response of glucose-induced insulin secretion.J Biol Chem. 2013 Sep 6;288(36):25851-25864. doi: 10.1074/jbc.M113.464420. Epub 2013 Jul 18. J Biol Chem. 2013. PMID: 23867458 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical